A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data.
from Diet and Weight Loss News -- ScienceDaily http://ift.tt/29fKfUm
No comments:
Post a Comment